NIAID Strategic Plan for COVID-19 Research
The NIAID Strategic Plan for COVID-19 Research details the institute’s priorities for controlling and ultimately ending the spread of the novel coronavirus (SARS-CoV-2) and the disease it causes (COVID-19).
Researcher Access to Clinical Data
NIAID's cloud-based, secure data platform enables sharing of anonymous patient-level clinical data to help generate new knowledge to treat and prevent infectious diseases such as COVID-19.
Antiviral Program for Pandemics
NIAID’s research program to develop safe and effective antivirals to combat SARS-CoV-2 will also build sustainable platforms for targeted drug discovery and development of antivirals against viruses with pandemic potential.
